Phase 1 Clinical Study of JTE-052A - Single and Multiple Dose study -
Latest Information Update: 07 Dec 2021
At a glance
- Drugs Delgocitinib (Primary)
- Indications Skin disorders
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Japan Tobacco
- 06 Jun 2016 New trial record